Search Results

There are 6373 results for: content related to: CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant

  1. IL28B genotype and the expression of ISGs in normal liver

    Liver International

    Volume 33, Issue 7, August 2013, Pages: 991–998, Zoe Raglow, Carly Thoma-Perry, Richard Gilroy and Yu-Jui Y. Wan

    Version of Record online : 24 MAR 2013, DOI: 10.1111/liv.12148

  2. You have free access to this content
    Interleukin-28B polymorphism in hepatitis C and liver transplantation

    Liver Transplantation

    Volume 19, Issue 1, January 2013, Pages: 49–58, Andres Duarte-Rojo, Matthew G. Deneke and Michael R. Charlton

    Version of Record online : 27 DEC 2012, DOI: 10.1002/lt.23554

  3. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 846–853, Senem C. Karataylı, Mithat Bozdayı, Ersin Karataylı, Tuğba Öztürk, Abbas A. Husseini, Rabia Albayrak, Muhip Özkan, Zeynep Kalaylıoğlu, Kendal Yalçın, Kubilay Çınar, Ramazan İdilman and Cihan Yurdaydın

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12595

  4. You have free access to this content
    Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

    HIV Medicine

    Volume 12, Issue 8, September 2011, Pages: 487–493, K Neukam, J Nattermann, N Rallón, A Rivero, A Caruz, J Macías, M Vogel, JM Benito, Á Camacho, JA Mira, C Schwarze-Zander, P Barreiro, A Martínez, JK Rockstroh, V Soriano and JA Pineda

    Version of Record online : 6 MAR 2011, DOI: 10.1111/j.1468-1293.2011.00912.x

  5. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 473–481, Haiqing Wu, Gangde Zhao, Fangxing Qian, Kehui Liu, Jingdong Xie, Huijuan Zhou, Jie Xu, Yumin Xu, Yan Han, Qing Xie and Hui Wang

    Version of Record online : 13 MAR 2014, DOI: 10.1111/liv.12491

  6. Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 482–488, Leonardo Mottola, Giovanni Cenderello, Valeria A. Piazzolla, Paolo Forte, Vito Carretta, Fabrizio Mecenate, Giuseppina Brancaccio, Rosalba Minisini, Massimo Zuin, Natalia Terreni, Monica Monti, Alberto Eraldo Colombo, Lorenzo Nosotti, Nicola Minerva, Ilaria Luzzitelli, Alba Kostandini, Giuseppe Cuccorese, Maurizio Russello, Rosanna Santoro and Alessandra Mangia

    Version of Record online : 17 JUL 2014, DOI: 10.1111/liv.12630

  7. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  8. High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity

    Liver International

    Volume 36, Issue 3, March 2016, Pages: 344–352, Susanne Johansson, Willem Talloen, Marianne Tuefferd, Jama Darling, Gregory Fanning, Michael W. Fried and Jeroen Aerssens

    Version of Record online : 6 SEP 2015, DOI: 10.1111/liv.12932

  9. You have free access to this content
    Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment

    Clinical Microbiology and Infection

    Volume 20, Issue 12, December 2014, Pages: 1237–1245, E. Riva, C. Scagnolari, O. Turriziani and G. Antonelli

    Version of Record online : 12 DEC 2014, DOI: 10.1111/1469-0691.12797

  10. You have free access to this content
    Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 2, July 2012, Pages: 91–103, Y. Chen, H.-X. Xu, L.-J. Wang, X.-X. Liu, R. I. Mahato and Y.-R. Zhao

    Version of Record online : 16 MAY 2012, DOI: 10.1111/j.1365-2036.2012.05131.x

  11. Association of HLA-DP/DQ, STAT4 and IL-28B variants with HBV viral clearance in Tibetans and Uygurs in China

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 886–896, Yun Liao, Bei Cai, Yi Li, Jie Chen, Binwu Ying, Chuanmin Tao, Min Zhao, Zhu Ba, Zhaoxia Zhang and Lanlan Wang

    Version of Record online : 5 AUG 2014, DOI: 10.1111/liv.12643

  12. Evolution of fibrosis during HCV recurrence after liver transplantation – influence of IL-28B SNP and response to peg-IFN and ribavirin treatment

    Journal of Viral Hepatitis

    Volume 20, Issue 11, November 2013, Pages: 770–778, M. Ackefors, J. Nyström, A. Wernerson, H. Gjertsen, A. Sönnerborg and O. Weiland

    Version of Record online : 23 APR 2013, DOI: 10.1111/jvh.12099

  13. A polymorphism linked to RRAS,SCAF1,IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers

    Liver International

    Volume 34, Issue 4, April 2014, Pages: 558–566, Luis M. Real, Antonio Caruz, Antonio Rivero-Juarez, Vicente Soriano, Karin Neukam, Antonio Rivero, Celia Cifuentes, José A. Mira, Juan Macías and Juan A. Pineda

    Version of Record online : 16 OCT 2013, DOI: 10.1111/liv.12330

  14. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  15. Impact of interleukin-28B genotype on in vitro and in vivo systems of hepatitis C virus replication

    Hepatology Research

    Volume 42, Issue 9, September 2012, Pages: 841–853, Kazuaki Chayama, C. Nelson Hayes and Michio Imamura

    Version of Record online : 23 APR 2012, DOI: 10.1111/j.1872-034X.2012.01002.x

  16. DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 108–119, Gregory Everson, Curtis Cooper, Christophe Hézode, Mitchell L. Shiffman, Eric Yoshida, Teresita Beltran-Jaramillo, Pietro Andreone, Savino Bruno, Peter Ferenci, Stefan Zeuzem, Michael Brunda, Sophie Le Pogam, Isabel Nájera, Julian Zhou, Mercidita T. Navarro, Athina Voulgari, Nancy S. Shulman and Ellen S. Yetzer

    Version of Record online : 12 FEB 2014, DOI: 10.1111/liv.12471

  17. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 890–895, Mostafa M. Ragheb, Nader A. Nemr, Rania M. Kishk, Mohamed F. Mandour, Mohamed M. Abdou, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Version of Record online : 14 OCT 2013, DOI: 10.1111/liv.12321

  18. Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients

    Liver International

    Volume 34, Issue 7, August 2014, Pages: e208–e216, Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Ayman A. Abdo, Faisal M. Sanai, Waleed K. Al-Hamoudi, Khalid A. Alswat, Hamad I. Al-Ashgar, Nisreen Z. Khalaf, Nisha A. Viswan and Mohammed N. Al Ahdal

    Version of Record online : 20 NOV 2013, DOI: 10.1111/liv.12347

  19. HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism

    Journal of Viral Hepatitis

    Volume 20, Issue 3, March 2013, Pages: 193–199, J. Stenkvist, A. Sönnerborg and O. Weiland

    Version of Record online : 20 AUG 2012, DOI: 10.1111/j.1365-2893.2012.01645.x

  20. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349